Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland.
Molecular Life Sciences PhD Program, Swiss Federal Institute of Technology and University of Zurich, Zurich, Switzerland.
Nat Commun. 2021 Feb 10;12(1):925. doi: 10.1038/s41467-021-21217-0.
Recent studies have revealed the importance of long noncoding RNAs (lncRNAs) as tissue-specific regulators of gene expression. There is ample evidence that distinct types of vasculature undergo tight transcriptional control to preserve their structure, identity, and functions. We determine a comprehensive map of lineage-specific lncRNAs in human dermal lymphatic and blood vascular endothelial cells (LECs and BECs), combining RNA-Seq and CAGE-Seq. Subsequent antisense oligonucleotide-knockdown transcriptomic profiling of two LEC- and two BEC-specific lncRNAs identifies LETR1 as a critical gatekeeper of the global LEC transcriptome. Deep RNA-DNA, RNA-protein interaction studies, and phenotype rescue analyses reveal that LETR1 is a nuclear trans-acting lncRNA modulating, via key epigenetic factors, the expression of essential target genes, including KLF4 and SEMA3C, governing the growth and migratory ability of LECs. Together, our study provides several lines of evidence supporting the intriguing concept that every cell type expresses precise lncRNA signatures to control lineage-specific regulatory programs.
最近的研究揭示了长非编码 RNA(lncRNAs)作为组织特异性基因表达调节剂的重要性。有充分的证据表明,不同类型的脉管系统经历严格的转录控制,以维持其结构、身份和功能。我们通过 RNA-Seq 和 CAGE-Seq,确定了人类皮肤淋巴管和血液血管内皮细胞(LECs 和 BECs)中谱系特异性 lncRNAs 的综合图谱。随后,对两种 LEC 和两种 BEC 特异性 lncRNA 的反义寡核苷酸敲低转录组谱分析,确定 LETR1 是全球 LEC 转录组的关键守门员。深入的 RNA-DNA、RNA-蛋白质相互作用研究和表型拯救分析表明,LETR1 是一种核反式作用 lncRNA,通过关键表观遗传因子调节关键靶基因的表达,包括 KLF4 和 SEMA3C,从而控制 LECs 的生长和迁移能力。总之,我们的研究提供了几条证据,支持了一个有趣的概念,即每个细胞类型都表达精确的 lncRNA 特征,以控制谱系特异性的调控程序。